Bristol-Myers Squibb Company 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-04-05 5:28 pm Purchase |
2020-12-31 | 13G | Sutro Biopharma, Inc. STRO |
BRISTOL MYERS SQUIBB CO BMY |
1,726,197 3.800% |
1,726,197 (New Position) |
Filing |